However, these Tam-Pt(IV) compounds were found to reverse the tamoxifen resistance of breast cancer, particularly that of MCF-7 (ERα+ breast cancer cells), but it was less effective toward MDA-MB-231 (ERα negative breast cancer cells). This evidence concerns the gene ESR1 and breast carcinoma.